Sofokast Plus tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). It works by stopping the virus that causes hepatitis C from spreading inside the body.
Do not take Sofokast Plus tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.
Sofokast Plus tablet is not recommended for patients below 18 years of age. Do not take this medicine if you are pregnant or breastfeeding. Use effective contraception during the treatment. The common side effects of this treatment are headache, tiredness, anemia, and nausea. Chronic hepatitis C virus

Price:
Price 3899 INR / Bottle
Minimum Order Quantity : 1 Bottle
Storage Instructions : Store below 30C
Physical Form : Tablets
Quantity : 1 Boxes
Ingredients : Dolutegravir
Price 13299 INR / Strip
Minimum Order Quantity : 1 Strip
Storage Instructions : Store below 30C
Physical Form : Tablets
Quantity : 1 Strip
Ingredients : Sofosbuvir
Price 2999 INR / Bottle
Minimum Order Quantity : 1 Bottle
Storage Instructions : Store below 30C
Physical Form : Tablets
Quantity : 1 Boxes
Ingredients : Dolutegravir
Price 6000.00 INR / Strip
Minimum Order Quantity : 1 Strip
Storage Instructions : Store below 30C
Physical Form : Tablets
Quantity : 1 Strip
Ingredients : Hepcdac 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.
![]() |
SURYA SPECIALITY PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |